1. Home
  2. CPBI vs NVNO Comparison

CPBI vs NVNO Comparison

Compare CPBI & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPBI
  • NVNO
  • Stock Information
  • Founded
  • CPBI 2023
  • NVNO 1987
  • Country
  • CPBI United States
  • NVNO United States
  • Employees
  • CPBI N/A
  • NVNO N/A
  • Industry
  • CPBI
  • NVNO Medical/Dental Instruments
  • Sector
  • CPBI
  • NVNO Health Care
  • Exchange
  • CPBI Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • CPBI 57.1M
  • NVNO 41.0M
  • IPO Year
  • CPBI N/A
  • NVNO N/A
  • Fundamental
  • Price
  • CPBI $14.84
  • NVNO $3.63
  • Analyst Decision
  • CPBI
  • NVNO
  • Analyst Count
  • CPBI 0
  • NVNO 0
  • Target Price
  • CPBI N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • CPBI 7.0K
  • NVNO 76.2K
  • Earning Date
  • CPBI 01-01-0001
  • NVNO 05-01-2025
  • Dividend Yield
  • CPBI N/A
  • NVNO N/A
  • EPS Growth
  • CPBI 29.70
  • NVNO N/A
  • EPS
  • CPBI 1.62
  • NVNO N/A
  • Revenue
  • CPBI $18,546,000.00
  • NVNO N/A
  • Revenue This Year
  • CPBI N/A
  • NVNO N/A
  • Revenue Next Year
  • CPBI N/A
  • NVNO $409.09
  • P/E Ratio
  • CPBI $9.18
  • NVNO N/A
  • Revenue Growth
  • CPBI 13.73
  • NVNO N/A
  • 52 Week Low
  • CPBI $9.96
  • NVNO $2.03
  • 52 Week High
  • CPBI $15.50
  • NVNO $6.48
  • Technical
  • Relative Strength Index (RSI)
  • CPBI 53.40
  • NVNO 71.27
  • Support Level
  • CPBI $14.70
  • NVNO $2.61
  • Resistance Level
  • CPBI $14.77
  • NVNO $3.97
  • Average True Range (ATR)
  • CPBI 0.08
  • NVNO 0.22
  • MACD
  • CPBI 0.03
  • NVNO 0.13
  • Stochastic Oscillator
  • CPBI 70.22
  • NVNO 79.64

About CPBI Central Plains Bancshares Inc.

Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: